Beta Wealth Group’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,875
Closed -$241K 109
2023
Q4
$241K Hold
3,875
0.13% 92
2023
Q3
$217K Buy
+3,875
New +$218K 0.13% 94
2023
Q2
Sell
-3,875
Closed -$211K 107
2023
Q1
$211K Hold
3,875
0.12% 98
2022
Q4
$242K Hold
3,875
0.16% 88
2022
Q3
$273K Hold
3,875
0.2% 74
2022
Q2
$220K Hold
3,875
0.15% 81
2022
Q1
$243K Hold
3,875
0.16% 82
2021
Q4
$252K Hold
3,875
0.18% 53
2021
Q3
$252K Hold
3,875
0.18% 53
2021
Q2
$246K Buy
+3,875
New +$229K 0.17% 55

Other funds holding AXNX

Beta Wealth Group's AXNX Position: Q1 2024 in Review

Beta Wealth Group sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 3,875 shares — an estimated $241K sold.

Beta Wealth Group first reported a position in AXNX in Q2 2021 and held it in 10 quarters. The position peaked at $273K in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Beta Wealth Group reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Beta Wealth Group sold 3,875 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $241K.
  • Beta Wealth Group first reported a position in Axonics, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Beta Wealth Group's Axonics, Inc. Common Stock position peaked at $273K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Beta Wealth Group's 13F filing for Q1 2024, filed 15 May 2024.